Skip to content
Home/Companies/Pharma/PrioThera
PrioThera

PrioThera

Pharma·Ireland·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns PrioThera?

PrioThera is currently owned by Earlybird Venture Capital through Earlybird Health (2017 vintage), since 2020.

Hand-verified · updated 2026-08-10

Earlybird Venture Capital
Investor
Earlybird Venture Capital
Earlybird Health · 2017 · VC

Key facts

HQIreland
SectorPharma
StatusActive
Websitepriothera.com

More from Earlybird Health

Other portfolio companies in the same fund.

Axon Vascular Europe
Active
MedTechUK· 2025
Haya Therapeutics
Haya Therapeutics
Active
BiotechSwitzerland· 2025
Hilo
Hilo
Active
MedTechSwitzerland· 2025
Portal Biotech
Active
BiotechUK· 2025
Rivia
Active
HealthTechSwitzerland· 2025
Gemma Biotherapeutics
Gemma Biotherapeutics
Active
BiotechUS· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track PrioThera

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy PrioThera?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on PrioThera.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue